G. Ramsay

Epidemiology · Intensive Care Medicine · 2003–2004

A researcher in the Science corpus: 3 papers; trusts 1 researcher and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

Whom G. Ramsay trusts

Their strongest outbound trust, strongest first, inferred from their citations.

  1. N. Steigbigel (in Epidemiology)

Who trusts G. Ramsay

  1. Jean-Louis Vincent (in Epidemiology)
  2. D. Remick (in Epidemiology)

Papers from G. Ramsay's perspective

Ordered by how strongly the researchers G. Ramsay trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care (Critical Care Medicine)
  2. A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. (Kidney International)
  3. Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock
  4. Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. (American Journal of Respiratory and Critical Care Medicine)
  5. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. (Journal of the American Medical Association (JAMA))
  6. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. (New England Journal of Medicine)
  7. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. (American Journal of Respiratory and Critical Care Medicine)
  8. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock (Current Infectious Disease Reports)
  9. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group.
  10. High-Dose Antithrombin III in Severe Sepsis: A Randomized Controlled Trial

Their papers